AI Article Synopsis

  • Newly published guidelines from the Japanese Gastroenterological Endoscopy Society (JGES) suggest proceeding with endoscopic procedures without stopping warfarin and stopping direct oral anticoagulants (DOACs) only on the day of the procedure.
  • A study analyzed the medical records of 344 patients who underwent hot-snare polypectomy while on anticoagulants, comparing post-polypectomy bleeding rates between those following the new guidelines and those who had anticoagulants interrupted with heparin-bridging.
  • Results indicated that the bleeding rates in patients following the new guidelines were not significantly different from those who had their anticoagulants interrupted, supporting the validity of JGES recommendations for managing anticoagulant therapy during polypectomy.

Article Abstract

Background: Newly published guidelines of the Japanese Gastroenterological Endoscopy Society (JGES) suggest to consider endoscopic procedures with high risk of bleeding without stopping warfarin and with stopping direct oral anticoagulants (DOACs) only on the day of the procedure. In this study, we aimed to test the validity of these recommendations.

Patients And Methods: We retrospectively reviewed medical records of 344 patients with anticoagulant therapy who underwent hot-snare polypectomy between January 2012 and October 2018. Patients (n = 132) with interruption of anticoagulants (3-7 days for warfarin and 2-3 days for DOACs before the procedure) and without heparin-bridging were excluded. Among the remaining 212 patients, the incidence of post-polypectomy bleeding was compared between the following 2 patient groups: patients who had interruption of anticoagulants with heparin-bridging (HB group, n = 139) and patients treated according to the new JGES guideline (FG group, n = 73).

Results: The rate of post-polypectomy bleeding (PPB) in FG group (9.6%) was not significantly different from that in HB group (12.9%, p = 0.5). In subgroup analysis, the incidence of bleeding in patients with warfarin (12.2%) and with DOAC (6.3%) in FG group was not significantly different from corresponding figures in HB group (14.2%, 0%). In multivariate analysis, number of resected polyps was associated with PPB, but the administration of anticoagulants according to the new guidelines was not a significant risk factor for PPB (p = .98).

Conclusions: Our study affirms the recommendations of JGES for the management of anticoagulants in patients who undergo colonic polypectomy regarding post-polypectomy bleeding.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-019-03373-4DOI Listing

Publication Analysis

Top Keywords

post-polypectomy bleeding
16
hot-snare polypectomy
8
direct oral
8
oral anticoagulants
8
interruption anticoagulants
8
patients
7
anticoagulants
6
group
6
bleeding
5
post-polypectomy
4

Similar Publications

Objectives: Patients with Peutz-Jeghers syndrome (PJS) require continuous medical management throughout their lives. However, few case series regarding the clinical course, polyp surveillance, and treatment, including endoscopic ischemic polypectomy (EIP) for pediatric patients with PJS, were reported. We analyzed the current status and clinical course of pediatric patients with PJS under the management of our institute, including those treated with EIP.

View Article and Find Full Text PDF

Post-endoscopic mucosal resection (EMR) bleeding, or clinically significant post-EMR bleeding, is influenced by factors such as polyp size, right-sided colonic lesions, laterally spreading tumors, anticoagulant use, and comorbidities like cardiovascular or chronic renal disease. The optimal prophylactic therapy for post-EMR bleeding remains unknown, with no consensus on specific criteria for its application. Moreover, prophylactic measures, including clipping, suturing, and coagulation, have produced mixed results.

View Article and Find Full Text PDF

Periendoscopic management of antithrombotic drugs: Is cold snare polypectomy the answer?

Gastroenterol Hepatol

November 2024

Gastrointestinal Endoscopy Unit, Digestive Diseases Department, Hospital Universitari i Politècnic La Fe, La Fe Health Research Institute (IISLaFe), Valencia 46026, Spain. Electronic address:

Patients undergoing colonoscopy are increasingly taking antithrombotic medication. These patients, who are generally older, also have a higher prevalence of colon polyps. Therefore, it is general practice to modify or discontinue antithrombotic treatment before colonoscopy, to reduce the risk of post-polypectomy bleeding (PPB).

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated sex-based differences in colonoscopy indications and findings by analyzing data from 287,930 colonoscopy procedures performed between 2016 and 2021.
  • Results showed that women were more likely to undergo colonoscopies due to abdominal pain, constipation, diarrhea, and anemia, while men had more procedures related to positive FOBT, rectal bleeding, and surveillance.
  • In terms of findings, men had higher rates of colorectal cancer and polyps, while women had better bowel preparation, underscoring the need for tailored approaches in diagnosing and managing gastrointestinal diseases based on sex.
View Article and Find Full Text PDF

Background: /Aims: Polypectomy is a procedure associated with a high risk of bleeding. Guidelines recommend uninterrupted aspirin use during polypectomy, whereas cessation of clopidogrel 5-7 days before polypectomy is recommended. The cold snare resection technique, with or without submucosal injection, is considered safer than conventional polypectomy using electrocoagulation for post-polypectomy bleeding.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!